Ausgabe 4/2024
Inhalt (21 Artikel)
Novel Topical Treatments for Itch
Rami H. Mahmoud, Omar Mahmoud, Georgia Biazus Soares, Gil Yosipovitch
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
Luca Potestio, Nello Tommasino, Giuseppe Lauletta, Fabrizio Martora, Matteo Megna
Virtual Learning Decreases the Carbon Footprint of Medical Education
Divya Sharma, Julianne Rizzo, Yvonne Nong, Lilia C. Murase, Sydney Fong, Kenny Lo, Misha Rosenbach, Raja Sivamani, Jenny E. Murase
Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene Expression Profile to Refine ART Guidance
Brent R. Moody, Aaron S. Farberg, Ally-Khan Somani, Walton A. Taylor
Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis
Lawrence F. Eichenfield, Linda F. Stein Gold, Charles Lynde, Lyn Guenther, Shoshana Greenberger, Chia-Yu Chu, Zara Ghodsi, Bonnie Vlahos, Paul Sanders, Amy Cha, Juliana M. Canosa
Interleukin-17A Inhibitors in Patients with Psoriasis and Tuberculosis Infection: A 2-Year Prospective Study on Safety Without Preventive Treatment
Chun-Xia He, Chao Wu, Li Zhang, Hong-Zhong Jin
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
Ying Li, Chengzhi Lv, Lin Dang, Bingjiang Lin, Juan Tao, Chunlei Zhang, Xiaoyong Zhou, Han Ma, Yi Lu, Rong Chen, Jinnan Li, Guanshen Dou, Yunsheng Liang, Yanhua Liang, Yuling Shi
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G. Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M. Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T. Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
April Armstrong, Alvaro González-Cantero, Saakshi Khattri, Guilherme Muzy, William N. Malatestinic, Anastasia Lampropoulou, Meghan Feely, Sophia Kyoungah See, Can Mert, Andrew Blauvelt
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
Michela Starace, Francesca Pampaloni, Elisabeth Lazaridou, Eirini Kyrmanidou, Alexander Stratigos, Aimilios Lallas, Alexander Katoulis, Dimitrios Sgouros, Federico Quadrelli, Luca Rapparini, Stephano Cedirian, Francesca Bruni, Lorenzo Ala, Alfredo Rossi, Bianca Maria Piraccini, Zoe Apalla
Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment
Manuel Pacareu Francès, Laura Vila-Vecilla, Valentina Russo, Hudson Caetano Polonini, Gustavo Torres de Souza
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
Tiago Torres, Anne Sohrt Petersen, Ulla Ivens, Albert Bosch Vilaro, John Stinson, José Manuel Carrascosa
The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
Sissel Brandt Toft Sørensen, Prethibha George, Oladayo Jagun, Robert Wolk, Lynne Napatalung, Samuel H. Zwillich, Lars Iversen, Vera Ehrenstein
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60
Alexander Egeberg, Jason E. Hawkes, Najwa Somani, Russel Burge, Kyoungah See, Gaia Gallo, Missy McKean-Matthews, Melinda Gooderham, George Han, April Armstrong
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J. Gabriel Vasquez
Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
Sergio Vañó-Galván, Alexander Egeberg, Bianca Maria Piraccini, Simran Marwaha, Catherine Reed, Erin Johansson, Frederick Durand, Anthony Bewley
Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis
Ling Chen, Yufan Cheng, Lu Peng, Xuesong Jia, Guangren Liu, Zhu Shen
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil
William J. Nahm, Evangelos V. Badiavas, Robert S. Kirsner, Carter J. Boyd, Anita A. Arthur, Sean Bae, John Shen
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature
Sarah Marie Hoffmann, Anna Luisa Hartmann, Pablo Nieratschker, Michael Berthold Mussler, Christoph Mathis Schempp
Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
Ruiyao Hu, Yue Wang, Fanzhang Meng, Zhimin Lin, Naigang Chen, Chen Li